AB Jets owners Andrew Bettis (left) and David Turner (right) celebrate the delivery of the company’s first Challenger 3500 business jet. (Source: Bombardier and AB Jets)
  • Bombardier (TSX:BBD.A) has delivered the first of three Challenger 3500 jets to charter operator AB Jets in Memphis, Tennessee, which currently operates a fleet of nine Learjet 60 aircraft
  • The Challenger’s 6,297-kilometre range expands AB’s horizons far beyond the Learjet’s capabilities, which top out at 4,454 km
  • Bombardier supports a customer fleet of more than 5,100 aircraft through 10 service facilities across six countries
  • Bombardier stock has added 77.08 per cent year-over-year

Bombardier (TSX:BBD.A) has delivered the first of three Challenger 3500 jets to charter operator AB Jets in Memphis, Tennessee, which currently operates a fleet of nine Learjet 60 aircraft.

The Challenger 3500 seats 10 and offers a maximum range of 6,297 kilometres and a maximum speed of 882 km per hour, supplementing its performance with the private jet industry’s first voice-controlled cabin, a 4K entertainment system, Nuage zero-gravity seats and the largest cabin display in its class.

AB’s move into the super mid-size business jet category is about enhancing the customer experience, according to Andrew Bettis, president of AB Jets, who said in Thursday’s news release that “this delivery is more than an aircraft handover; it represents the future of AB Jets.”

“The Challenger 3500 is our flagship, a jet that elevates our ability to serve clients with more comfort, extended range and the same uncompromising focus on safety and reliability that defines our culture. We’re proud to bring this aircraft home and begin the next chapter of our story,” Bettis went on to say.

The addition will also enhance the charter operator’s supplemental lift services to brokers, flight departments and other operators, including access to more destinations beyond the Learjet 60’s 4,454-km range, adding another feather in the cap of the company’s more than two-decade history.

Jean-Christophe Gallagher, Bombardier’s executive vice president of aircraft sales and Bombardier Defense, expanded upon this point, noting that the Challenger 3500 “will provide AB Jets’ customers with a best-in-class business aviation experience … and an exciting new world of opportunities.”

About Bombardier

Bombardier designs, builds, modifies and maintains a line of jets for individuals, businesses, governments and militaries around the world. Its customers operate a fleet of more than 5,100 aircraft supported by 10 service facilities across six countries. The company operates aerostructure, assembly and completion facilities in Canada, Mexico and the United States.

Bombardier stock (TSX:BBD.A) last traded at C$191.58. The stock has added 77.08 per cent year-over-year. 

Join the discussion: Find out what investors are saying about this private jet stock and the Challenger 3500 aircraft on the Bombardier Inc. Bullboard and make sure to explore the rest of Stockhouse’s stock forums and message boards.

Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein.

For full disclaimer information, please click here.


More From The Market Online

@ the Bell: Markets sink as geopolitical tensions rise & rates hold steady

Canada’s main stock index edged lower on Wednesday as renewed tensions between the US and Iran...
Nintendo Switch 2 image via Nintendo

Nintendo stock sinks after Direct fails to impress investors

Nintendo shares surged during the Direct but then fell around 10 per cent by the close, as investors were underwhelmed by the game lineup.

Tech selloff tests the AI IPO boom as market volatility returns

AI-driven tech stocks like Nvidia (NASDAQ:NVDA) are pulling back after a huge run, triggering sharp swings in major indexes.

Apotex Health completes largest life sciences IPO in TSX history

Apotex Health (TSX:APTX) began trading today on the TSX, marking the largest life sciences IPO by total proceeds in the exchange's history.